To effectively convert differential gene expressions in cancer patients into actionable insights and repurposed drug treatments, follow these steps:
For instance, the FDA-approved drug Raltegravir has been identified as a potential inhibitor of the ADAM17 metalloprotease, which is implicated in inflammation and cancer progression. This was determined through molecular docking studies that assessed its binding affinity to the target .
import pandas as pd import numpy as np from sklearn.preprocessing import StandardScaler from scipy.stats import ttest_ind # Load gene expression data # Assuming 'data.csv' contains gene expression data with columns: 'gene', 'expression', 'cancer_type' data = pd.read_csv('data.csv') # Filter for significant DEGs significant_degs = data[(data['p_value'] < 0.05) & (data['fold_change'].abs() > 2)] # Perform t-test for differential expression cancer_samples = data[data['cancer_type'] == 'Cancer']['expression'] normal_samples = data[data['cancer_type'] == 'Normal']['expression'] # Calculate t-test t_stat, p_val = ttest_ind(cancer_samples, normal_samples) # Identify potential drug targets potential_targets = significant_degs[significant_degs['p_value'] < 0.05] # Output results print('Significant DEGs:', potential_targets)